Target intelligence / Profile preview

ATP-sensitive inward rectifier potassium channel (KATP) (KATP)

Target
KATP
Molecular classification
Ion channel, Inward-rectifier potassium channel, ABC transporter family
01

Overview

The ATP-sensitive inward rectifier potassium channel (KATP) in pancreatic beta cells is a hetero-octameric protein complex consisting of four pore-forming Kir6.2 subunits (encoded by KCNJ11) and four regulatory sulfonylurea receptor 1 (SUR1) subunits (encoded by ABCC8) [1, 2]. This channel serves as a critical metabolic sensor that couples the intracellular ATP/ADP ratio to the cell's membrane potential [3]. Under high glucose conditions, increased ATP production leads to channel closure, resulting in membrane depolarization, calcium influx, and the subsequent secretion of insulin [2, 4]. Genetic mutations in the KATP channel subunits are primary causes of neonatal diabetes mellitus and congenital hyperinsulinism [5]. The channel is the primary therapeutic target for sulfonylureas and meglitinides, which promote insulin release in type 2 diabetes by inducing channel closure [6]. Conversely, KATP channel openers like diazoxide are utilized to inhibit excessive insulin secretion in hypoglycemic disorders [1].

Other names
ATP-sensitive potassium channelKir6.2/SUR1 complexSulfonylurea receptor 1Inward rectifier potassium channel 6.2KCNJ11/ABCC8 complex
02

Mechanism of action

Sulfonylureas and meglitinides bind to the SUR1 subunit of the KATP channel, causing it to close; this leads to membrane depolarization, activation of voltage-gated calcium channels, and insulin exocytosis. KATP channel openers like diazoxide maintain the channel in an open state, hyperpolarizing the cell and inhibiting insulin release.

03

Biological functions

Insulin secretionGlucose sensingMembrane potential regulationMetabolic coupling
04

Disease associations

Type 2 diabetes mellitusNeonatal diabetes mellitusCongenital hyperinsulinismHyperinsulinemic hypoglycemia
05

Safety considerations

HypoglycemiaWeight gainOff-target cardiovascular effects due to SUR2 interactionFluid retentionSecondary failure in long-term sulfonylurea use
06

Interacting drugs

Glibenclamide

6 more in the full profile.

07

Biomarkers

Blood glucoseC-peptideSerum insulinKCNJ11 genetic variantsABCC8 genetic variants

Beyond the preview

Go deeper on ATP-sensitive inward rectifier potassium channel (KATP) (KATP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-sensitive inward rectifier potassium channel (KATP) (KATP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call